G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2016 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Medical Officer Raj Malik, MD, will present a company overview at the Wedbush PacGrow Healthcare Conference. The presentation will take place on Wednesday, August 17, at 1:55 p.m. ET at the Le Parker Méridien in New York City.

For additional information on the conference, visit:
https://www.wedbush.com/services/cmg/equities-division/mgmt-access-events

About G1 Therapeutics, Inc.

G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing G1T28, a potential first-in-class drug candidate, and G1T38, a potential best-in-class compound, in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.

Visit www.g1therapeutics.com for more information.

Contact: Gregory Mossinghoff G1 Therapeutics 919-251-5980 gjm@g1therapeutics.com Media: Laura Bagby 6 Degrees Communications 312-448-8098 lbagby@6degreespr.com

Source: G1 Therapeutics